Clinical Beta Program

Sanjeevni is currently in an exclusive Clinical Beta phase, partnering with world-class genomic institutes to refine our Bayesian diagnostic models and clinical NLP engines.

Overview

clinicalBeta.s1P1 clinicalBeta.s1P2 clinicalBeta.s1P3

Defining the Frontier of Precision Medicine

clinicalBeta.s1P1

Iterative Refinement and 'Gold Standard' Mapping

clinicalBeta.s2P1

Transitioning to Broad Clinical Utility

As we accumulate more data and demonstrate consistent, superior diagnostic performance, the Clinical Beta Program will gradually expand. We are developing a clear, evidence-based roadmap for transitioning Sanjeevni into a front-line clinical tool. This involves not only technical refinement but also navigating the complex regulatory landscapes of the FDA and EMA. We are working closely with regulatory experts to ensure that Sanjeevni meets all the requirements for a Class II Medical Device (Software as a Medical Device - SaMD).

Iterative Refinement

We continuously refine our HPO mapping layers based on feedback from clinical geneticists and real-world cases.

Safety & Compliance

clinicalBeta.s5Desc